Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06209827
Other study ID # IFLBZD16
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2018
Est. completion date December 31, 2021

Study information

Verified date January 2024
Source Andalusian Health Service
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aimed to assess the effectiveness of a comprehensive, multicomponent intervention utilizing education and support for Benzodiazepines withdrawal compared to standard care.


Description:

The excessive use of benzodiazepines (BZDs) presents significant health concerns and high healthcare costs, particularly in Spain, where usage rates are among the highest globally. In Andalusian, over a 10% of the population use BZDs long-term, prompting the need for safe and effective reduction strategies. This study aimed to assess the effectiveness of a comprehensive, multicomponent intervention utilizing education and support for BZD withdrawal compared to standard care. The intervention involved educational discussions, consultations with health professionals, and letters supported by multiple scientific societies.


Recruitment information / eligibility

Status Completed
Enrollment 472
Est. completion date December 31, 2021
Est. primary completion date December 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - users of health centre's with more than 4 weeks of benzodiazepines use. - users of health centre's over 18 years of age. Exclusion Criteria: - users of health centre's with mental disorder. - users of health centre's terminal. - users of health centre's with alcohol dependence. - users of health centre's with dementia. - users of health centre's who had intellectual disabilities. - users of health centre's unable to cooperate with the questionnaires.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Intervention for reducing benzodiazepines long-term use.
Comprehensive, multicomponent intervention utilizing education and support for benzodiazepines. Family doctor, nurse, community pharmacist and social workers: carried out informative discussion with the patient with by providing educational material. They informed patients about the advantages, disadvantages and alternatives to benzodiazepines including a descending benzodiazepines schedule to minimize withdrawal symptoms. It briefly explained the professionals' concerns about the continued use of benzodiazepines and offers possible solutions. If the patient requested a withdrawal, he/she was referred to the doctor.

Locations

Country Name City State
Spain Ingrid Ferrer López Sevilla

Sponsors (2)

Lead Sponsor Collaborator
Andalusian Health Service Andalusian School of Public Health

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of dispensing of benzodiazepines. Number of dispensing of benzodiazepines, measured at the level of the participant. 3.5 years
Secondary Knowledge Knowledge: Empower questionary, measured at the level of the participant. 6 months
Secondary Life Quality Quality of life:Functional Status Measurement Sheets by coop World Organisation of Family Doctors (COOP/ WONCA):
The six COOP-WONCA Charts are described by vignettes and measured at the level of the participant: physical fitness, feelings, daily activities, social activities, change in health and overall health.
WONCA: World Organisation of Family Doctors
6 months
See also
  Status Clinical Trial Phase
Completed NCT03688542 - Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module N/A
Completed NCT02545257 - Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care N/A
Completed NCT03655405 - Randomised, Controlled Trial of an Individual Deprescribing Intervention for Nursing Homes Residents N/A
Completed NCT02052505 - Reducing Inappropriate Prescribing for Psychiatric Patients Using Nurse-led Medication Reviews N/A
Recruiting NCT06437444 - Asthma Crisis in Paediatrics: Impact of a Care Pathway in Primary and Hospital Care N/A
Active, not recruiting NCT04022850 - De-implementation of Low-value Pharmacological Prescriptions N/A
Completed NCT04294901 - Engaging Patients to Promote Deprescribing N/A
Recruiting NCT03501108 - Discontinuation of Long-term Medications in Older People Entering Nursing Home Care N/A
Enrolling by invitation NCT03689049 - SPIDER: A Research & QI Collaboration Supporting Practices in Improving Care for Complex Elderly Patients N/A
Completed NCT02435290 - Enhancement of the Prediction of Chemotherapy Prescribing Errors for Oncology Patients N/A
Completed NCT03539276 - An Intervention to Reduce Inappropriate Medications in Long-term Care Residents With Severe Dementia N/A
Active, not recruiting NCT02744963 - Carefully seLected and Easily Accessible at No Charge Medications N/A
Recruiting NCT05875623 - Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults N/A
Completed NCT04586595 - A Randomised Pilot Study of the REVISiT Intervention N/A
Completed NCT03245879 - Antibiotic Stewardship in Small Hospitals N/A
Not yet recruiting NCT06129474 - Deprescribing Inappropriate Proton Pump Inhibitors N/A
Recruiting NCT04028583 - Tool for Inappropriate Prescription Evaluation: The TaIPE Study N/A
Completed NCT03254472 - Big Data Analysis of the Use of bIomarkers Concentration N/A
Completed NCT05454644 - Effectiveness of a Person-centred Prescription Model at the End of Life N/A
Completed NCT02918643 - Using a Mobile Application as a Support at the Prescription of Appropriate Medications for Elderly N/A